Skip to main content

Solid Tumors News (Page 2)

FDA Approves Keytruda (pembrolizumab) as First Cancer Treatment for any Solid Tumor with a Specific Genetic Feature

May 23, 2017 – The U.S. Food and Drug Administration today granted accelerated approval to a treatment for patients whose cancers have a specific genetic feature (biomarker). This is the first time...

Ask a question

To post your own question to our community, sign in or create an account.

Further information

Related condition support groups

Cancer

Related drug support groups

methotrexate, Keytruda, docetaxel